Information already released gives us a pretty good idea that revenue for the quarter will be ~$1.4m
Spend last quarter was ~$1.9m
Hence, if spend remains at $1.9m, then the result is $500k short of break even.
It is possible spend may be down. Last quarter's $1.9m was higher than previous due to additional spend of $170k on fleet and increased spend on componentry (~$150k extra). Will these have been one off? Or are they "needed" again this quarter with expanding fleet size.
My projections do not show break even until Q2/Q3 calendar year 2021. That is, one or two quarters away yet.
In my view, confirmation of the $1.4m revenue - up 25% on the previous quarter - should generate support for the share price.
...
- Forums
- ASX - By Stock
- SP3
- Illegal Dumping
Illegal Dumping, page-6
Featured News
Add SP3 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.484M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 116582 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 22775 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 116582 | 0.015 |
1 | 142857 | 0.014 |
2 | 70000 | 0.013 |
1 | 80000 | 0.012 |
3 | 250001 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 22775 | 1 |
0.017 | 23075 | 1 |
0.019 | 660000 | 1 |
0.020 | 1286181 | 2 |
0.021 | 203398 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
SP3 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online